| 0 (0%) | 01-26 16:52 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 55.02 | 1-year : | 59.74 |
| Resists | First : | 47.11 | Second : | 51.15 |
| Pivot price | 45.14  |
|||
| Supports | First : | 40.57 | Second : | 33.75 |
| MAs | MA(5) : | 41.8 |
MA(20) : | 45.5 |
| MA(100) : | 49.19 |
MA(250) : | 0 | |
| MACD | MACD : | -1.7 |
Signal : | -1.1 |
| %K %D | K(14,3) : | 13.1  |
D(3) : | 11.3 |
| RSI | RSI(14): 33.9 |
|||
| 52-week | High : | 62.18 | Low : | 33.42 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ HNGE ] has closed above bottom band by 20.5%. Bollinger Bands are 52.3% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 2 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 43.02 - 43.26 | 43.26 - 43.49 |
| Low: | 40.6 - 40.86 | 40.86 - 41.1 |
| Close: | 41.18 - 41.6 | 41.6 - 41.99 |
Fri, 23 Jan 2026
Analyst Expectations For Hinge Health's Future - Benzinga
Fri, 23 Jan 2026
Freedom Capital Markets Initiates Coverage of Hinge Health (HNGE) with Buy Recommendation - Nasdaq
Fri, 23 Jan 2026
Freedom Capital Markets Initiates Hinge Health(HNGE.US) With Buy Rating, Announces Target Price $59 - 富途资讯
Tue, 20 Jan 2026
Hinge Health Inc (HNGE) Trading Down 3.2% on Jan 20 - GuruFocus
Fri, 16 Jan 2026
Will Hinge Health Inc. (HNGE) beat estimates again in its next earnings report? - MSN
Fri, 16 Jan 2026
Hinge Health (HNGE) Valuation Check After Recent Share Price Moves And Conflicting P/S And DCF Signals - simplywall.st
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 38 (M) |
| Shares Float | 32 (M) |
| Held by Insiders | 5.3 (%) |
| Held by Institutions | 105.3 (%) |
| Shares Short | 4,800 (K) |
| Shares Short P.Month | 1,920 (K) |
| EPS | -5.45 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 2.64 |
| Profit Margin | -99.8 % |
| Operating Margin | -4 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 53.2 % |
| Gross Profit (p.s.) | 11.1 |
| Sales Per Share | 14.09 |
| EBITDA (p.s.) | -14.34 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 146 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | -7.63 |
| PEG Ratio | 0 |
| Price to Book value | 15.74 |
| Price to Sales | 2.94 |
| Price to Cash Flow | 10.8 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|